Financhill
Back

Ulta Beauty, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
76

ULTA
Ulta Beauty, Inc.

Last Price:
$657.35
Seasonality Move:
5.89%
Sell
38

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.22
Seasonality Move:
-13.28%
Buy
76
Ulta Beauty, Inc. (ULTA) is a Buy

Is Ulta Beauty, Inc. a Buy, Sell or Hold?

  • The current Ulta Beauty, Inc. [ULTA] share price is $655.36. The Score for ULTA is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • ULTA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ULTA Stock Price Chart

What is Ulta Beauty, Inc.'s stock price today?

  • The Ulta Beauty, Inc. share price today is $655.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ULTA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ULTA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 22.03 Buy
Relative Strength Index (14 RSI): 76.55 Buy
Chaikin Money Flow: 361882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (572.33 - 626.11) Buy
Bollinger Bands (100): (509.25 - 582.07) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.96 Buy
Relative Strength Index (14 RSI): 66.03 Buy
Chaikin Money Flow: 3428689 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.13 - 49.63) Buy
Bollinger Bands (100): (35.09 - 47.19) Buy

ULTA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 622.58 Buy
20-day SMA: 608.16 Buy
50-day SMA: 559.26 Buy
200-day SMA: 491.87 Buy
8-day EMA: 628.57 Buy
20-day EMA: 606.59 Buy
50-day EMA: 575.26 Buy
200-day EMA: 508.04 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.2 Buy
20-day SMA: 48.28 Buy
50-day SMA: 45.42 Buy
200-day SMA: 36 Buy
8-day EMA: 48.68 Buy
20-day EMA: 47.84 Buy
50-day EMA: 45.56 Buy
200-day EMA: 40.15 Buy

Ulta Beauty, Inc. Earnings Growth & ULTA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.10 per share, an increase next quarter of $3.22 per share, an increase this year of $1.50 per share, and an increase next year of $2.77 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.55 per share.

Ulta Beauty, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):